MARTHA CARRANZA: Open Payments
NPI 1376614925 · MISSION VIEJO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$12,479 in 55 payments from 21 companies in 2025. Trend: 2023 $33,026 · 2024 $16,272 · 2025 $12,479
Speaker / faculty: $11,600Food & beverage: $879
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 18 | $11,632 |
| Abbott Laboratories | 9 | $261 |
| Amgen Inc. | 4 | $66 |
| Dexcom, Inc. | 3 | $64 |
| Tandem Diabetes Care, Inc. | 2 | $50 |
| Novo Nordisk Inc | 2 | $46 |
| SANOFI-AVENTIS U.S. LLC | 2 | $40 |
| Regeneron Healthcare Solutions, Inc. | 1 | $36 |
| Lilly USA, LLC | 2 | $34 |
| Ascendis Pharma Endocrinology Inc | 1 | $26 |
Products named: OMNIPOD, FREESTYLE LIBRE 3, Dexcom G6 Transmitter, t:slim X2 Insulin Pump with Control-IQ, Repatha, TZIELD, EVKEEZA, JARDIANCE.
Industry payments across CA — which companies pay providers there.
